{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:35:12Z","timestamp":1789684512628,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2215\/cjn.10221014","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T21:42:51Z","timestamp":1429306971000},"page":"800-807","source":"Crossref","is-referenced-by-count":120,"title":["The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis"],"prefix":"10.2215","volume":"10","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230601","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-013-2746-7","article-title":"Calcific uraemic arteriolopathy: A rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.","volume":"29","author":"Brandenburg","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R2-12-20230601","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/ajkd.1998.v32.pm9740153","article-title":"Cutaneous necrosis from calcific uremic arteriolopathy.","volume":"32","author":"Coates","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R3-12-20230601","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy.","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"R4-12-20230601","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease.","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int"},{"key":"R5-12-20230601","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","article-title":"Calciphylaxis: Natural history, risk factor analysis, and outcome.","volume":"56","author":"Weenig","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R6-12-20230601","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: A systematic review.","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-12-20230601","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5301\/JN.2011.6366","article-title":"Calciphylaxis: A still unmet challenge.","volume":"24","author":"Brandenburg","year":"2011","journal-title":"J Nephrol"},{"key":"R8-12-20230601","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5414\/CNP59463","article-title":"A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies.","volume":"59","author":"Don","year":"2003","journal-title":"Clin Nephrol"},{"key":"R9-12-20230601","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11255-008-9373-4","article-title":"Calciphylaxis: Calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.","volume":"40","author":"Hayden","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R10-12-20230601","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfs466","article-title":"Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.","volume":"28","author":"Kramann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R11-12-20230601","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A case-control study of calciphylaxis in Japanese end-stage renal disease patients.","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R12-12-20230601","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000348806","article-title":"Statin use and calcific uremic arteriolopathy: A matched case-control study.","volume":"37","author":"Nigwekar","year":"2013","journal-title":"Am J Nephrol"},{"key":"R13-12-20230601","first-page":"160","article-title":"Calcific uremic arteriolopathy in association with low turnover uremic bone disease.","volume":"52","author":"Mawad","year":"1999","journal-title":"Clin Nephrol"},{"key":"R14-12-20230601","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/hdi.12087","article-title":"Calciphylaxis and subtotal parathyroidectomy: a double-edged sword.","volume":"17","author":"Katikaneni","year":"2013","journal-title":"Hemodial Int"},{"key":"R15-12-20230601","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1093\/ndt\/gfr777","article-title":"Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.","volume":"27","author":"Chertow","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R16-12-20230601","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-12-20230601","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview.","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-12-20230601","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1210\/jc.2013-2975","article-title":"The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.","volume":"98","author":"Parfrey","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-12-20230601","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0039-6060(97)90212-9","article-title":"Calciphylaxis in patients on hemodialysis: A prevalence study.","volume":"122","author":"Angelis","year":"1997","journal-title":"Surgery"},{"key":"R21-12-20230601","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/sdi.12175","article-title":"Vitamin K antagonists: Beyond bleeding.","volume":"27","author":"Kr\u00fcger","year":"2014","journal-title":"Semin Dial"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:18Z","timestamp":1786369518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00012"}},"subtitle":["The EVOLVE Trial"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10221014","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}